(Q42982531)

English

Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice

scientific article published on 3 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ahmad R. Dehpour

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Mehdi Ghasemi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hamed Shafaroodi

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Saeed Nazarbeiki

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hossein Meskar

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Pouria Heydarpour

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Abbas Ghasemi

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Saman Shafaat Talab

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Pouya Ziai

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Arash Bahremand

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

3 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

171-178

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Effects of chronic lithium treatment on limbic seizure generation in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium inhibits the modulatory effects of morphine on susceptibility to pentylenetetrazole-induced clonic seizure in mice: involvement of a nitric oxide pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium Carbonate and Convulsive Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Influence of lithium carbonate on patients with temporal epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium therapy and signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The actions of ouabain and lithium chloride on cytosolic Ca2+ in single chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Conditions that lithium inhibits or potentiates vasopressin V1 receptor-mediated platelet aggregation and [Ca++]i mobilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Calcium, lithium, and circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium attenuates the effects of dynorphin A(1-13) on inositol 1,4,5-trisphosphate and intracellular Ca2+ in rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Decreased agonist-stimulated Ca2+ response in neutrophils from patients under chronic lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Increased sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: effect of lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Glutamate-mediated calcium signaling: a potential target for lithium action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Altered seizure susceptibility in mice lacking the Ca(v)2.3 E-type Ca2+ channel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Probable calcium spikes in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Participation of calcium spikes during intrinsic burst firing in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Calcium-dependent phosphorylation of synaptic vesicle proteins and its possible role in mediating neurotransmitter release and vesicle function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Possible Role of Calcium-Dependent Protein Phosphorylation in Mediating Neurotransmitter Release and Anticonvulsant Action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Extracellular free calcium and potassium during paroxsmal activity in the cerebral cortex of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Selective central nervous system calcium channel blockers--a new class of anticonvulsant agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Add-on therapy in epilepsy with calcium entry blockers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant and neuroprotective effects of the novel calcium antagonist NP04634 on kainic acid-induced seizures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Evaluation of the modulatory role of nimodipine in seizures induced by kainic acid and pentylenetetrazole in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lipophilic 4-imidazoly-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Modulation of cortical nitric oxide synthase, glutamate, and redox state by nifedipine and taurine in PTZ-kindled mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Calcium antagonist nimodipine in intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Overview of the Current Animal Models for Human Seizure and Epileptic Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: interaction between opioid and cannabinoid systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Mouth breathing increases the pentylenetetrazole-induced seizure threshold in mice: a role for ATP-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Effect of disulfiram in combination with L-tryptophan and lithium on pentylenetetrazol-induced seizure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Acute effects of lithium on hippocampal kindled seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The effects of acute and chronic lithium treatment on rat submandibular salivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Enhancement of calcium currents in rat hippocampal CA1 neurons induced by kindling epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Pathophysiological mechanisms of brain damage from status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant drug mechanisms. Phenytoin, phenobarbital, and ethosuximide and calcium flux in isolated presynaptic endings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Common anticonvulsants inhibit Ca2+ uptake and amino acid neurotransmitter release in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Calcium, neuronal hyperexcitability and ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Intracellular potentials of cortical neurons during focal epileptogenic discharges

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Dendritic mechanisms underlying penicillin-induced epileptiform activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Enhanced calcium influx in hippocampal CA3 neurons of spontaneously epileptic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Specific suppression of pentylenetetrazol-induced epileptiform discharges in CA3 neurons (hippocampal slice, guinea pig) by the organic calcium antagonists flunarizine and verapamil

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Motor cortical epileptic foci in vivo: actions of a calcium channel blocker on paroxysmal neuronal depolarizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Paroxysmal neuronal depolarizations in the rat motorcortex in vivo: intracellular injection of the calcium agonist BAY K 8644.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Effects of some anti-epileptic, neuroleptic and gabaminergic drugs on convulsions induced by D,L-allyglycine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Suppression of pentylenetetrazole seizures by oral administration of a dihydropyridine Ca2+ antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Suppression of recurrent generalized tonic-clonic seizure discharges by intraventricular perfusion of a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

NMDA receptors in clinical neurology: excitatory times ahead

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Exitatory Amino Acids in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant action of excitatory amino acid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Combined blockade of AMPA and NMDA receptors in the brain of rats prevents pentylenetetrazole-induced clonic and tonic-clonic seizures without ataxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Effects of MK-801 and phenytoin on flurothyl-induced seizures during development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Suppression of audiogenic seizures in DBA/2 mice by two new dipeptide NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Effects of N-methyl-D-aspartate receptor subunit antagonists on regulation of susceptibility to audiogenic seizures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Ketamine controls prolonged status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Felbamate monotherapy: controlled trial in patients with partial onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Felbamate for partial seizures: results of a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Felbamate monotherapy for partial-onset seizures: an active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Chronic treatment with antidepressants, verapamil, or lithium inhibits the serotonin-induced intracellular calcium response in individual C6 rat glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Inhibitory effects of lithium ion on intracellular Ca2+ mobilization in the rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Chronic lithium treatment attenuates intracellular calcium mobilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant activity of MK-801 and nimodipine alone and in combination against pentylenetetrazole and strychnine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2010.04.002

7 January 2021

Identifiers

10.1016/J.YEBEH.2010.04.002

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42982531&oldid=1975835971"